Korean Stock Flows

GC Genome (KRX: 340450)

지씨지놈 KOSDAQ Biotech & Pharma 그외 기타 전문, 과학 및 기술 서비스업
Close (Oct 13, 2026)
₩9,580
-3.91%
Market cap
₩0T ($0.2B)
52-week range
₩4,100 – ₩10,480
P/E (12M fwd) · P/B · Div yield
32.11 · 2.89 · 0%
trailing 51.78 · consensus of 1 analysts

Who is buying GC Genome?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net bought ₩4.8bn ($4M) of GC Genome, the 73rd largest foreign net purchase among 1828 KOSDAQ stocks. Institutions net bought ₩7.4bn ($6M) and retail investors net sold ₩12.7bn ($10M) over the same window. Foreigners were net buyers on 9 of the 20 sessions.

Foreign investors hold 4.69% of GC Genome's listed shares (KRX ownership data as of Oct 13, 2026), up from 2.93% twenty sessions earlier and 0.63% a year ago.

The stock closed at ₩9,580 on Oct 13, 2026: +59.14% over 20 sessions, +40.47% year-to-date, +35.69% over one year. The 52-week range is ₩4,100 – ₩10,480.

At ₩9,580 the stock trades at 32.11× 12-month-forward consensus earnings (1 analysts), 30.17× on FY2027 estimates. The trailing P/E published by KRX is 51.78×, based on the last completed fiscal year.

GC Genome share price, last 60 trading days (KRW)
10,553 8,354 6,156 3,957 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+4.1bn +2bn -2bn -4.1bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩9,580 +₩0.9bn ₩-1.0bn ₩-0.4bn
2026-10-12 ₩9,970 ₩-0.1bn +₩1.7bn ₩-1.5bn
2026-10-08 ₩9,870 +₩0.0bn ₩-0.7bn +₩0.8bn
2026-10-07 ₩10,140 ₩-0.8bn +₩0.6bn +₩0.5bn
2026-10-06 ₩10,200 +₩4.1bn +₩1.6bn ₩-5.8bn
2026-10-02 ₩8,880 ₩-1.3bn +₩0.6bn +₩0.7bn
2026-10-01 ₩9,270 +₩0.4bn +₩2.3bn ₩-2.6bn
2026-09-30 ₩8,660 ₩-0.6bn +₩0.2bn +₩0.4bn
2026-09-29 ₩8,760 +₩0.8bn +₩0.7bn ₩-1.5bn
2026-09-28 ₩8,670 +₩0.9bn +₩0.8bn ₩-2.1bn
2026-09-23 ₩8,180 +₩1.2bn +₩0.5bn ₩-1.6bn
2026-09-22 ₩7,290 ₩-0.4bn +₩0.1bn +₩0.7bn
2026-09-21 ₩6,770 ₩-0.1bn ₩-0.1bn +₩0.1bn
2026-09-18 ₩6,900 ₩-0.0bn ₩-0.0bn +₩0.2bn
2026-09-17 ₩7,000 +₩0.1bn ₩-0.0bn ₩-0.2bn
2026-09-16 ₩6,730 ₩-0.2bn +₩0.1bn ₩-0.4bn
2026-09-15 ₩6,060 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-09-14 ₩6,010 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-11 ₩5,820 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-10 ₩5,940 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-09 ₩6,020 +₩0.2bn +₩0.1bn ₩-0.3bn
2026-09-08 ₩5,500 +₩0.1bn ₩-0.1bn +₩0.0bn
2026-09-07 ₩5,500 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-04 ₩5,510 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-03 ₩5,420 ₩-0.0bn ₩-0.1bn +₩0.2bn
2026-09-02 ₩5,630 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-01 ₩5,890 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-08-31 ₩5,920 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-08-28 ₩5,970 +₩0.1bn +₩0.1bn ₩-0.1bn
2026-08-27 ₩5,600 ₩-0.2bn +₩0.0bn +₩0.1bn
2026-08-26 ₩5,550 +₩0.1bn +₩0.1bn ₩-0.1bn
2026-08-25 ₩5,310 ₩-0.0bn ₩-0.1bn +₩0.1bn
2026-08-24 ₩5,390 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-08-21 ₩5,390 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-08-20 ₩5,820 ₩-0.2bn +₩0.2bn ₩-0.0bn
2026-08-19 ₩5,690 +₩0.0bn +₩0.1bn ₩-0.2bn
2026-08-18 ₩5,560 +₩0.0bn +₩0.1bn ₩-0.1bn
2026-08-14 ₩5,620 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-08-13 ₩5,690 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-12 ₩5,640 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-11 ₩5,610 ₩-0.0bn +₩0.1bn ₩-0.1bn
2026-08-10 ₩5,470 +₩0.2bn +₩0.1bn ₩-0.2bn
2026-08-07 ₩5,230 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-06 ₩5,240 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-05 ₩5,230 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-04 ₩5,100 +₩0.3bn ₩-0.0bn ₩-0.2bn
2026-08-03 ₩4,865 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-31 ₩4,600 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-07-30 ₩4,310 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-29 ₩4,360 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-07-28 ₩4,745 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-07-27 ₩4,985 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-07-24 ₩5,080 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-23 ₩5,220 ₩-0.1bn +₩0.1bn +₩0.0bn
2026-07-22 ₩4,890 ₩-0.1bn +₩0.1bn +₩0.0bn
2026-07-21 ₩5,130 ₩-0.1bn +₩0.2bn ₩-0.1bn
2026-07-20 ₩4,740 ₩-0.0bn +₩0.1bn ₩-0.1bn
2026-07-16 ₩4,730 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-07-15 ₩4,620 +₩0.0bn +₩0.1bn ₩-0.1bn
2026-07-14 ₩4,465 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-07-13 ₩4,450 ₩-0.0bn ₩0.0bn +₩0.0bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.9bn +$1M ₩-1.0bn ₩-0.4bn
5 days +₩4.1bn +$3M +₩2.3bn ₩-6.5bn
20 days +₩4.8bn +$4M +₩7.4bn ₩-12.7bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying GC Genome stock?

Over the last 5 sessions foreign investors net bought ₩4.1bn ($3M) of GC Genome; over 60 sessions they net bought ₩4.5bn ($3M); since Jan 1, 2026 they net bought ₩7.1bn ($5M). Over 20 sessions the stock is the 73rd largest foreign net purchase among 1828 KOSDAQ stocks.

How much of GC Genome do foreign investors own?

Foreign investors own 4.69% of GC Genome's shares as of Oct 13, 2026, versus 0.63% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩7.4bn ($6M) and retail investors net sold ₩12.7bn ($10M) of GC Genome. Retail investors have been supplying the shares that foreigners and institutions are buying.

Is GC Genome listed on KOSPI or KOSDAQ?

GC Genome (지씨지놈) trades on KOSDAQ under KRX code 340450 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2025 ₩32bn ($24M) – ₩1bn ($1M) ₩4bn ($3M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows